PSG Equity and Rivean Capital Acquire Corilus
July 4, 2024
PSG Equity has made a strategic investment in Corilus alongside existing investor Rivean Capital, with Rivean reinvesting via a continuation vehicle. Corilus, a Ghent-based provider of cloud-based medical software used by more than 30,000 care providers and with ~450 employees, will use the new capital to accelerate product development (including GenAI capabilities) and pursue organic and inorganic expansion across Europe.
- Buyers
- PSG Equity, Rivean Capital
- Targets
- Corilus N.V.
- Industry
- Healthcare Services
- Location
- East Flanders, Belgium
- Transaction Type
- Recapitalization
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.